Thanks Freesoul. So, as we thought, recruitment is slow - 'relatively rare' disease - and news therefore likely to be some way off. Does that also suggest the market for this particular application of our product is small? On the other hand, the huge positive would be successful application in humans, which when put together with the asthma mice results and the size of that market ...
OOO
Ann: Positive Data from CYP MSCs in 2nd Preclinical Asthma Study, page-36
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |